REN and acute respiratory distress syndrome: Since the renin-angiotensin system plays an important role in the occurrence of acute respiratory distress syndrome (ARDS), which can also be seen in COVID-19 patients, it is plausible to consider the potential therapeutic use of this medication in the future for treating COVID-19 patients [108].